ComplianceWire® Emergency Use Qualification is now available
ComplianceWire® Emergency Use Qualification is now available for vaccine developers and manufacturers to expedite the qualification of licensed or contracted manufacturers, helping them maintain the integrity and quality of their vaccine regardless of manufacturer. It is also available for governmental bodies to maintain public trust by providing proof that individual administrators are qualified to safely dispense COVID-19 vaccines.
Compliant with 21 CFR Part 11 and EU Annex 11
ComplianceWire® Emergency Use Qualification are streamlined and purpose-built instances of ComplianceWire®, Our best-in-class, web-based platform is designed specifically for medical device, pharmaceutical and biologics industries to effectively and efficiently automate the creation, delivery, and reporting of role-based training, qualification and compliance programs. ComplianceWire® was built from the ground up to be fully compliant with 21 CFR Part 11 and EU Annex 11 validation requirements. This time-tested technology is used extensively by U.S. and global medical device, pharmaceutical, and biologics companies as well as global regulatory authorities in the U.S., China and India.
ComplianceWire® Emergency Use Qualification features and benefits:
Rapid implementation
Part 11 compliant records and e-signatures
Intuitive user interface
Automated role-based assignment of training
Version-controlled content with periodic review workflow
Granular and flexible security role definitions
Robust audit trails
Real-time reporting and data visualizations
External systems integration
X
Get connected with our team
Have questions, need specifics? Let's get this conversation started.
Please wait…